Standards of proof, standards of practice, and proof of standards: A tale of two trials

被引：5

作者：

Browman, GP ^{[1
]}

机构：

[1] Tom Baker Canc Clin, Calgary, AB, Canada

[2] Univ Calgary, Calgary, AB, Canada

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 12期

关键词：

D O I：

10.1200/JCO.2005.11.910

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2583 / 2585

页数：3

共 9 条

[1] Scope and impact of financial conflicts of interest in biomedical research - A systematic review [J].

Bekelman, JE ;

Li, Y ;

Gross, CP .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (04) :454-465

[2] Weekly epoetin alfa maintains hemoglobin, improves quality of life, and reduces transfusion in breast cancer patients receiving chemotherapy [J].

Chang, J ;

Couture, F ;

Young, S ;

McWatters, KL ;

Lau, CY .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (12) :2597-2605

[3] Placebo effects in oncology [J].

Chvetzoff, G ;

Tannock, IF .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (01) :19-29

[4] Is the placebo powerless?: An analysis of clinical trials comparing placebo with no treatment. [J].

Hróbjartsson, A ;

Gotzsche, PC .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (21) :1594-1602

[5] Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized, double-blind, placebo-controlled trial [J].

Littlewood, TJ ;

Bajetta, E ;

Nortier, JWR ;

Vercammen, E ;

Rapoport, B .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (11) :2865-2874

[6]

Quirt I, 1997, Cancer Prev Control, V1, P241

[7] Use of epoetin in patients with cancer: Evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology [J].

Rizzo, JD ;

Lichtin, AE ;

Woolf, SH ;

Seidenfeld, J ;

Bennett, CL ;

Cella, D ;

Djulbegovic, B ;

Goode, MJ ;

Jakubowski, AA ;

Lee, SJ ;

Miller, CB ;

Rarick, MU ;

Regan, DH ;

Browman, GP ;

Gordon, MS .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (19) :4083-4107

[8] Epoetin treatment of anemia associated with cancer therapy: A systematic review and meta-analysis of controlled clinical trials [J].

Seidenfeld, J ;

Piper, M ;

Flamm, C ;

Hasselblad, V ;

Armitage, JO ;

Bennett, CL ;

Gordon, MS ;

Lichtin, AE ;

Wade, JL ;

Woolf, S ;

Aronson, N .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (16) :1204-1214

[9] Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy [J].

Witzig, TE ;

Silberstein, PT ;

Loprinzi, CL ;

Sloan, JA ;

Novotny, PJ ;

Mailliard, JA ;

Rowland, KM ;

Alberts, SR ;

Krook, JE ;

Levitt, R ;

Morton, RF .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (12) :2606-2617

← 1 →